Entries by Phil Case

AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States

AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States SAN JOSE, Calif., March 24, 2020 — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the allowance […]

AnPac Bio Files Coronavirus Detection Patent and Initiates Related Research Project

FOR IMMEDIATE RELEASE AnPac Bio Files Coronavirus Detection Patent and Initiates Related Research Project San Jose, CA, February 27, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that […]

AnPac Bio Gains Two New Insurance Customers

San Jose, CA, February 6, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has gained two new insurance customers in China for its cancer screening and detection […]

AnPac Bio Announces Pricing of Initial Public Offering

FOR IMMEDIATE RELEASE AnPac Bio Announces Pricing of Initial Public Offering San Jose, CA, January 30, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has priced its […]

ANPAC BIO APPOINTS NOBEL PRIZE WINNER DR. MICHAEL LEVITT AS CHIEF CONSULTANT TO LEAD ANPAC’S PIONEERING EFFORTS IN CANCER SCREENING

ANPAC BIO APPOINTS NOBEL PRIZE WINNER DR. MICHAEL LEVITT AS CHIEF CONSULTANT TO LEAD ANPAC’S PIONEERING EFFORTS IN CANCER SCREENING San Jose, CA – December 11, 2019 – Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio” or the “Company”) announced today the appointment of Professor Michael Levitt of Stanford University to be the Chief Consultant of […]

©2021 Anpac Bio-Medical Science Co., Ltd.